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The insulin-like family of growth factors (IGFs) – composed of insulin, and insulin-like growth factors I (IGF1) and II
(IGF2) – provides essential signals for the control of testis development and function. In the testis, IGFs act in an
autocrine-paracrine manner but the extent of their actions has been underestimated due to redundancies at both
the ligand and receptor levels, and the perinatal lethality of constitutive knockout mice. This review synthesizes the
current understanding of how the IGF system regulates biological processes such as primary sex determination,
testis development, spermatogenesis and steroidogenesis, and highlights the questions that remain to be explored.
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La famille des facteurs de croissance de type insuline, composée de l'insuline et des deux facteurs de croissance
ressemblant à l'insuline que sont l'IGF-I et l'IGF-II, est essentielle pour le contrôle du développement et de la
fonction testiculaire. Ces facteurs agissent de manière autocrine et paracrine entre les différents types de cellules
germinales et somatiques qui composent le testicule. Cependant, leur étude dans le contexte testiculaire reste
complexe et l'étendue de leurs actions est généralement sous-estimée, notamment du fait de redondances
fonctionnelles tant au niveau des ligands que de leurs récepteurs, mais également en raison de la létalité périnatale
observée chez les souris invalidées pour ces gènes. Le but de cette revue est d'offrir à la fois une synthèse des
connaissances sur la fonction des IGFs au cours de la détermination du sexe, du développement testiculaire, de la
spermatogenèse et de la stéroïdogenèse, mais aussi d’évoquer les axes de recherches en cours et de mettre en
lumière les questions qui restent à explorer.
Keywords in French: IGF-I, IGF-II, Insuline, Cellules de Sertoli, Cellules de Leydig, Spermatogenèse, Détermination
sexuelle, TesticuleIntroduction
Male fertility depends on proper testis function. The
testis is specified in the fetus from a bipotential gonad
and its development follows an intricate course of
genetic, hormonal, and growth factor expression. When
properly executed this process leads to normal testicular
function, which includes the production of mature
sperm and testosterone. Spermatogenesis is a complex
biological process that involves the proliferation and* Correspondence: Serge.Nef@unige.ch
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unless otherwise stated.differentiation of diploid spermatogonia into mature hap-
loid spermatozoa capable of fertilization. Testosterone
production relies on the endocrine action of hormones re-
leased from the brain and testosterone acts locally in the
testis to stimulate spermatogenesis. In addition, autocrine-
paracrine signaling of growth factors in the testis is essen-
tial for proper testis function. Thus, male fertility, testis
function and spermatogenesis are regulated by a complex
interplay of autocrine, paracrine, and endocrine factors.
The insulin family of growth factors (insulin, insulin-
like growth factors I (IGF1) and II (IGF2) are small
single-chain mitogenic polypeptides that provide essen-
tial signals for the control of growth, metabolism and re-
productive functions [1,2]. In particular, the insulin/IGFLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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growth, proliferation, differentiation and survival and af-
fects nearly every organ and system in the body [3,4].
Importantly, it also plays a major role in the proper
development and function of the testis. Although repro-
ductive capability is regulated by the hypothalamic-
pituitary-gonadal axis [5], the activity of local gonadal
factors, such as those of the insulin/IGF family, modulate
reproductive performance. For example, Igf1 null males
are infertile dwarfs and exhibit a reduction of greater
than 80% in both spermatogenesis and serum testoster-
one levels [6]. This not only highlights the overall import-
ance of IGF signaling for body growth and development,
but also emphasizes the critical role of IGFs in reproduct-
ive function.
More recent studies utilizing mouse functional genet-
ics and the Cre/Lox system have evaluated the role of
some of the receptors, ligands, and signaling molecules
of the insulin/IGF signaling pathway and have provided
more detailed information that underscores its indis-
pensable role in various aspects of testicular develop-
ment and function [7-10]. However, the precise roles of
IGFs in various facets of testicular development, sperm-
atogenesis and steroidogenesis are still unknown. Our
relatively limited understanding arises from several com-
plexities, including redundancies between IGFs, their
receptors, and their intracellular modulators; the embry-
onic or early postnatal lethality of mutant animals; and the
complex intratesticular autocrine-paracrine regulation. Re-
cent data have suggested that certain cell types within the
testis may be a source of IGF production and that the syn-
thesis of these local IGFs may function via autocrine-
paracrine action within the testis to regulate various
aspects of testicular development and function.
The purpose of this review is to synthesize the avail-
able data derived from studies in both laboratory ani-
mals and humans regarding the role of the insulin family
of growth factors in male reproductive development and
function. To provide perspective, we begin with a brief
overview of the players involved and their biological ac-
tions. We then describe the essential roles of IGFs dur-
ing sex determination and testicular development, and
how they modulate the function of Sertoli cells (SCs),
germ cells (GCs), and Leydig cells (LCs). Finally, we draw
conclusions from the current data and provide insight into
unresolved issues and future experimentation.
The IGF family and their receptors
Insulin, IGF1 and IGF2 modulate a variety of cellular ac-
tivities including cell survival, proliferation, differenti-
ation and metabolism [3,4]. The physiological effects of
these factors are mediated through the activation of two
related tyrosine kinase receptors: the insulin receptor
(INSR), and the type-I insulin-like growth factor receptor(IGF1R). INSR and IGF1R are heterotetrameric glycopro-
teins composed of two extracellular α subunits and two
transmembrane β subunits linked together by disulfide
bridges (see Figure 1 and [11]).
The complexity of insulin/IGF signaling results from
the multiplicity of ligands (insulin, IGF1, IGF2), recep-
tors (INSR, IGF1R), IGF binding proteins (IGFBP1 to 6),
and IGFBP proteases, as well as complex downstream
signaling pathways. Although they provide one source of
complexity, the INSR and IGF1R themselves are quite
similar, sharing 84% amino acid similarity in the β sub-
unit cytoplasmic region, where the tyrosine-specific kinase
domain is found, 64-67% similarity in the extracellular α
subunit region [12], and 100% similarity in the ATP bind-
ing domain. Interestingly, additional complexity arises
from the existence of hybrid INSR/IGF1R receptors. Both
INSR and IGF1R are the products of single genes, with
two subunits being derived from a single chain precursor
to give each αβ subunit complex. Two αβ dimers are
linked with disulfide bonds to form the resulting tetramer.
However, when αβ dimers from each gene are linked
with disulfide bonds, hybrid INSR-IGF1R complexes are
formed, which serve as an additional receptor isoform. A
third layer of complexity results from differential mRNA
splicing of the INSR α subunit into two isoforms, which
increases the number of potential receptors. INSR-A
lacks exon 11, which encodes 12 amino acids near the
C-terminus of the α subunit in INSR-B [13]. As a result
of these factors, there are five potential receptors from the
two receptor genes. Finally, variable binding affinities add
another level of intricacy to insulin/IGF signaling. The af-
finity of INSR-A and INSR-B isoforms and IGF1R towards
each insulin/IGF ligand differs significantly (Figure 1). In-
sulin binds with high affinity to INSR-A and INSR-B but
also binds with a lower affinity to IGF1R and the hybrid
receptors INSR-A/IGF1R and INSR-B/IGF1R [14,15].
IGF1 preferentially binds to IGF1R and the hybrid recep-
tors, but also binds to INSR-A and INSR-B with a lower af-
finity [16-20]. IGF2 binds to IGF1R and INSR-A with an
affinity close to that of insulin, and also binds to INSR-A/
IGF1R and INSR-B/IGF1R albeit with lower affinity [14].
IGF2 also binds to the cation-independent mannose-6-
phosphate/IGF2 receptor (M6P/IGF2R), but this receptor
lacks intrinsic tyrosine kinase activity and probably serves
as a mechanism to clear circulating IGF2 [21].
Transduction of signals initiated by ligands in the in-
sulin/IGF signaling pathway is mediated by a complex,
highly integrated network that activates several pro-
cesses. Figure 2 briefly illustrates these signaling path-
ways. IGF ligands bind to the extracellular α subunits,
transmitting a signal across the plasma membrane that
activates the intracellular tyrosine kinase domain of the
β subunit. The receptor then undergoes a series of phos-
phorylation reactions in which one β subunit in the
Figure 1 Receptors for insulin, IGF1 and IGF2. INSR and IGF1R are composed of two αβ dimers which associate to form heterotetrameric
complexes. The αβ dimers are linked together by disulfide bonds and two dimers are also linked by disulfide bonds to form the tetramer. The α
subunit is the extracellular portion of the receptor while the β subunit spans the membrane and its cytoplasmic portion interacts with IRS proteins
which are key intracellular mediators of insulin/IGF signaling. Single αβ dimers are derived from separate genes and the INSR has two splice variants,
INSR-B and INSR-A. Each variant shares the same membrane-spanning β subunit (dark blue) but differs in the extracellular α subunit (light pink or dark
pink, respectively). The IGF1R has different α and β subunits compared to the INSR (dark green). These combinations of αβ dimers allow for
hybrid receptors, which bind insulin, IGF1, and IGF2 with differing affinities. The schematic shows the αβ dimers, α2β2 hybrid receptors, and the known
ligands that bind each receptor. Relative binding affinities are represented by arrows, where a solid arrow signifies a higher binding affinity than a
broken arrow.
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on its adjacent β subunit [22]. Interestingly, unlike other
receptor tyrosine kinases, which bind directly to the cyto-
plasmic tails of downstream effectors, the INSR and the
IGF1R utilize insulin receptor substrate (IRS) proteins to
mediate the binding of intracellular effectors [23]. Four
IRS proteins, named IRS1-4, have been identified [24]
and are linked to the activation of two major signaling
pathways: phosphatidyl-inositol 3-kinase (PI3K) and
mitogen activated protein kinase (MAPK), both of which
are associated with proliferation, differentiation, metabol-
ism, and cell survival [24,25]. Nevertheless, it is becoming
increasing clear that IGF1 signals via other pathways
such as the Janus Kinase/Signal Transducer and Activa-
tor of Transcription (JAK-STAT) pathway, which pro-
vides further intracellular crosstalk and cell-specific
effects of IGF1 [26]. Whether this signaling pathway is im-
portant for testicular function and development remains to
be determined, however the presence of STAT proteins in
structural components of human sperm suggests that their
role is different from their transcription factor activity in
somatic cells [27]. A further level of insulin/IGF1signaling
complexity has been revealed by recent studies in various
cells and tissues that indicate INSR and IGF1R are able to
translocate to the cell nucleus and function like transcrip-
tion factors by binding to specific promoters and en-
hancers to control gene expression (for review see [28]).
To date, no such studies have been performed in the testis
but genomic effects of INSR and IGF1R would provide yetanother layer of complexity to insulin/IGF1 signaling and
the challenges facing researchers in the future.
Biological effects of insulin and IGFs
IGF1 and IGF2 are single chain polypeptides, with 62%
sequence identity to proinsulin [11] and are produced by
almost every cell in the body, unlike insulin which is
specifically expressed in the pancreatic β cells of the is-
lets of Langerhans. The availability of IGFs is modulated
by at least six high-affinity binding proteins, which in-
crease the half-life of IGF in serum, prevent the over-
stimulation of cell growth or excessive apoptosis [29],
and regulate the transport of IGFs and their interactions
with receptors [30]. The IGF system is part of a major
growth-promoting signaling system [3] involved in em-
bryonic and postnatal development. While IGF1 has
continuous function throughout development [18,19],
IGF2 is essential only for normal embryonic growth
[31,32]. Since the PI3K and MAPK pathways are involved
in a plethora of cellular activities, insulin/IGF signaling
regulates and/or is associated with a multitude of func-
tions. Alterations in the insulin/IGF signaling system are
associated with significant pathologies including diabetes
and cancer, along with dwarfism, dementia, decreased
longevity, and various metabolic diseases [33].
Insulin
Insulin is the most potent of the known anabolic hor-
mones, and is essential for appropriate tissue development,
Figure 2 A simplified view of insulin/IGF1 signaling. Insulin/IGF1 signaling is mediated by a complex, highly integrated network that controls
several processes. Two major pathways are activated by insulin/IGF1 signaling, the ATK/PI3K pathway and the ERK/MAPK pathway, which are
involved in several cellular processes such as metabolism, cell growth, proliferation, and apoptosis. Activation of the INSR/IGF1R by insulin/IGF1
binding leads to autophosphorylation of the β subunits and the receptor tyrosine kinase subsequently phosphorylates IRS proteins on their
tyrosine residues. This creates recognition sites for additional effector molecules containing SH2 domains, such the p85 regulatory subunit of PI3K
(which activates the AKT/PI3K pathway and is mainly responsible for the metabolic actions of insulin/IGF1) and GRB2 (which activates the ERK/
MAPK pathway and primarily regulates cell growth and differentiation). Additionally, the INSR and IGF1R can phosphorylate other substrates, such
as SHC and GAB1, which link multiple pathways. Together, these signals stimulate a variety of different downstream biological effects including
mitogenesis, gene expression, glucose transport, and glycogen synthesis.
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stasis [34]. Insulin is secreted by the β cells of the
pancreatic islets of Langerhans in response to increased
circulating levels of glucose, and regulates glucose homeo-
stasis by reducing hepatic glucose output via decreased
gluconeogenesis and glycogenolysis and increasing the rate
of glucose uptake into muscle and adipose tissue [35]. In-
sulin also profoundly affects lipid metabolism, increasing
lipid synthesis in liver and fat cells and attenuating fatty
acid release from triglycerides in muscle and adipose tissue
[22]. It also plays an indirect role in the regulation of fetal
growth by modulating the expression of IGFs, and has dir-
ect effects on adipose tissue and the proliferation of the
cells within the fetus [4]. A striking feature of insulin ex-
pression is that it is almost completely restricted to pancre-
atic β cells and its effects are therefore mediated in an
endocrine manner. Despite a few publications suggesting a
link between insulin and testis development and function
[36,37], there is no direct evidence to confirm that insulin
plays a role in this process.IGF1
IGF1 is primarily produced in the liver but is also syn-
thesized by almost all tissues in the body [38], and plays
a significant role in overall growth and adult body size,
while also sustaining postnatal development, including
reproductive functions [18,39]. Local production of IGF1
plays a major role in the growth of tissues [40], and due
to the overall pattern of IGF production during develop-
ment, is considered to be more important for postnatal
growth and development than insulin or IGF2 [11]. Re-
sults from studies in humans with deficiencies in IGF1
or IGF1R are consistent with those in mice, and indicate
that normal IGF1 and IGF1R activity is required for
proper growth and development. The clinical phenotype
of individuals with homozygous IGF1 defects consists
of severely reduced pre- an postnatal growth, extreme
microcephaly, sensorineural deafness, failure to thrive,
and poor feeding during infancy and early childhood,
while those with heterogeneous defects in IGF1 or IGF1R
show a similar but less severe phenotype [41-43].
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IGF1 is preferentially expressed in SCs, with reduced
expression found in primary spermatocytes and LCs.
IGF1R on the other hand is highly expressed in second-
ary spermatocytes and early spermatids, with reduced
expression in SCs and LCs [44]. While Igf1 null male
mice exhibit intrauterine growth retardation, postnatal
growth failure and infertility characterized by a severe
decline in spermatogenesis and testosterone production
[6], this study also highlights the difficulties in delineat-
ing the numerous roles of IGF1 in the testis with a con-
stitutive knockout.
IGF2
IGF2 is a single polypeptide, like IGF1, with which it
also shares 70% of its amino acid sequence [11]. The
Igf2 gene is part of a cluster of imprinted genes [45], and
is therefore only produced from the paternal allele,
the maternal allele being transcriptionally silent [32,46].
IGF2 plays a fundamental role in embryonic and fetal
development, whereas its role in postnatal development
appears to be less significant, as it can largely be re-
placed by IGF1. IGF2 regulates trophoblast development
and function at the feto-maternal interface and is an im-
portant factor in the determination of body size. Dele-
tion of Igf2 results in placental insufficiency and reduced
fetal weight [31,47], whereas its overexpression leads to
increased size [48]. Most defects reported in Igf2 null
mice are associated with intrauterine growth restriction
[49,50] and while no testicular defects have been de-
scribed in Igf2-deficient mice, this does not preclude a
putative role of IGF2 in testis development and function.
The inherent redundancies in the IGF signaling system
increase the difficulties in ascertaining the role of IGF2
in testicular function, as the biological actions of IGF2
may be masked by other IGFs. Stage-specific developmen-
tal studies in testis cell-specific conditional Igf2 knockout
models may help clarify these issues.
Taken together, these data highlight the importance of
the insulin family of growth factors in reproduction,
growth, and development. However the use of constitu-
tive KO models leads to a multitude of effects in mul-
tiple cell types, making it difficult to draw decisive
conclusions about which cell types in the testis are spe-
cifically affected. In addition, many constitutive KO models
of the insulin family of growth factors result in embryonic
or early postnatal lethality, making this method less than
ideal for revealing the precise roles of these ligands and
receptors in gonadal function.
IGFs, sex determination and testis development
Sex determination and the sex-specific differentiation
of bipotential gonads require distinct male and female
genetic programs. This also involves the interdependentassembly of several somatic cell types, together with
GCs, which requires a coordinated signaling program
resulting in the development of either testes or ovaries.
By embryonic day (E) 10.5 in mice, bipotential gonads
arise from the genital ridges and are composed of prim-
ordial germ cells and steroidogenic factor 1-positive
(SF1+) somatic cells, which include the supporting and
steroidogenic cell precursors. In XY individuals, sex de-
termination then begins with the transient expression of
the Sex-determining Region of the Y chromosome (Sry),
which in concert with SF1, triggers Sox9 upregulation
and the differentiation of supporting cell precursors into
SCs [51-54]. SCs subsequently act as organizing centers
to enclose GCs, form testis cords and orchestrate the
differentiation of all other cell types including fetal LCs,
prospematogonia and peritubular myoid cells [55-60]. In
the absence of Sry expression, a robust female-specific
genetic program is initiated in XX gonads leading to
ovarian differentiation.
In recent years, increasing evidence has emerged that
the insulin family of growth factors plays an essential
role in gonad development and sex determination. In
particular, insulin/IGF signaling is absolutely required
for sex determination and testis differentiation in mice
[7,9]. XY mice that are mutant for both Insr and Igf1r
develop ovaries and exhibit a completely female pheno-
type. Further studies have shown that mouse embryos
lacking both Insr and Igf1r failed to develop testes due
to a reduction in Sf1 gene expression and a failure of Sry
upregulation. Moreover, they exhibited reduced prolifer-
ation rates of somatic progenitor cells in both XX and
XY gonads prior to sex determination [9]. In addition,
the drastic reduction and delay in Sry expression in Insr;
Igf1r double KO animals was correlated with the lack of
upregulation of key testis genes such as Sox9, Fgf9, and
Ptgds, and the absence of SCs, LCs and overall testis for-
mation. Interestingly, while a few SOX9+ cells were
found in E12.5 XY double KO gonads, these were absent
at later stages, suggesting that in addition to Sox9 activa-
tion, maintenance of Sox9 expression was also impaired
in mutant XY gonads. Recent studies have demonstrated
that the first event triggered by the onset of SRY expres-
sion is the immediate accumulation of glycogen within
SC precursors [61]. This energy storage seems to be crit-
ical, as disruption of glycogen synthesis and accumula-
tion results in the failure of Sox9 upregulation, testis
cord formation and overall testis development. Interest-
ingly, glycogen storage within pre-SCs appears to be
dependent on the activation of the PI3K pathway, which
is known to be activated by both insulin and IGFs [11].
In double KO Insr-Igf1r null embryos, there is also a
delay in ovarian differentiation, which suggests that re-
gardless of the genetic sex, gonads lacking insulin signal-
ing remain in an undifferentiated state with no clear
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several days. Expression analyses during sex determin-
ation revealed that significant fractions of both the tes-
ticular and ovarian pathways were prematurely altered,
which may explain the incapacity of mutant gonads to
develop into either ovaries or testes at the normal time
of sex determination [9]. These studies showed for the
first time that, should a gonad remain uncommitted at
the normal time of sex determination, it remains in an
undifferentiated state for several days until the ovarian
differentiation program finally takes over at E16.5.
IGFs are major factors regulating SC number, testis size
and FSH action
SCs are the only somatic cells of the seminiferous epi-
thelium and are mainly committed to sustaining sperm-
atogenesis. As a result of this essential role, testis size
and sperm production are directly correlated to the total
number of adult SCs [62]. Although several local growth
factors and hormones have been reported to influence
the number of SCs, such as follicle-stimulating hor-
mone (FSH) [62-65] thyroid hormone, activin, fibroblast
growth factor, epidermal growth factor, transforming
growth factor α, and glial cell line-derived neurotropic
factor (GDNF) [12,66-72], a recent report revealed that
IGFs are the most important growth factor in regulating
SC number and testis size. Pitetti et al. [10], utilizing a
conditional KO approach, investigated whether the IGF
system is required for SC and GC development and func-
tion. When both Insr and Igf1r were inactivated specific-
ally in SCs there was a 72% reduction in testis size and a
79% reduction in daily sperm production in adult testes.
This resulted from the reduced proliferation of immature
SCs during late fetal and early neonatal development.
This reduction in total SC number and testis size was
more severe than in single mutants, revealing the con-
certed action of both INSR and IGF1R in testicular devel-
opment. Although Insr, Igf1r, and Insr;Igf1r mutant mice
all exhibited reduced SC number and testis size, and
drastic declines in sperm production, they were fertile,
indicating that the absence of IGF signaling in SCs does
not impair spermatogenesis directly [10]. An improved
understanding of the mediation of SC number and testis
size by insulin/IGF signaling pathways was provided by
animal studies of IRS proteins. Mice with a complete
absence of Irs2 show a 45% reduction in testis weight,
with significantly fewer SCs, spermatogonia, spermato-
cytes, elongated spermatids, and spermatozoa, whereas
testicular development in Irs1-deficient mice is not al-
tered [8]. These data indicate that IRS2 plays a critical
role in testicular development, potentially by mediating
IGF signaling during embryonic and early postnatal de-
velopment. Nevertheless, as is the case with constitutive
knockout models, the specific effects of IRS1 or IRS2 onSC development cannot be confirmed in this model due
to their extensive roles in other tissues. Nevertheless,
taken together, results from recent studies underscore
the indispensable role that the insulin/IGF signaling
pathway plays in the regulation of SC number, testis size,
and daily sperm output.
Interestingly, insulin and IGF receptors also play a cru-
cial role in mediating FSH action. FSH is considered one
of the major endocrine hormones that regulate SC
proliferation during testicular development [62-64]. Al-
though FSH acts through a G protein–coupled receptor,
its actions are intricately interconnected with IGF path-
ways, potentially through common downstream signal-
ing pathways or via FSH-dependent secretion of IGFs. In
fact, FSH amplifies IGF1-mediated activation of AKT
signaling by SCs [73-76]. In mice lacking the FSH recep-
tor specifically in SCs, testis weight and SC number
were reduced by approximately 55-60% [65], compared
with >70% for SC-Insr;Igf1r mice [10]. In vivo experi-
ments have shown that the neonatal action of FSH re-
quires the insulin/IGF signaling pathway to mediate its
proliferative effects on immature SCs [10]. Interactions
akin to those observed in the testis between the IGF sys-
tem and FSH have also been reported in the ovary. In rat
granulosa cells treated with IGF1, Fshr expression and
mRNA stability were increased [77]. Furthermore, FSH-
induced phosphorylation of AKT and stimulation of ste-
roidogenic genes and estradiol production in these cells
requires IGF1R activation [78]. Collectively, these results
from both granulosa cells and SCs suggest a crucial role
for IGFs in mediating FSH action in the gonads. These
data also reinforce the view that the local production of
insulin/IGFs is the major intratesticular signal regulating
SC number, testis size and sperm output in mammals. In
addition, although several factors play a role in the prolif-
eration and maturation of SCs [79], insulin/IGF signaling
is likely to represent the major hormonal signal involved
in the establishment of a normal number of SCs.
IGFs are dispensable for differentiating GCs during
spermatogenesis
Spermatogenesis is a highly complex process in which
diploid spermatogonial stem cells differentiate into ma-
ture haploid spermatozoa. Multiple genetic, hormonal,
and growth factor pathways must act in concert to
continually produce mature sperm. It remains unclear
whether IGFs act directly on the GC lineage to regulate
their survival and differentiation into mature haploid
spermatozoa. IGF1 and IGF1R are expressed in sperm-
atogonia and spermatocytes [80], implying a role in
spermatogenesis as potential autocrine or paracrine
factors, although little is known about their specific
functions. When either Insr, Igf1r, or both receptors to-
gether are inactivated specifically in the GC lineage,
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males are viable and fertile [10]. Furthermore, all repro-
ductive parameters are normal including testicular hist-
ology, testis size, and sperm production, indicating that
insulin/IGF signaling is expendable in GCs throughout
the meiotic and postmeiotic stages of spermatogenesis.
In contrast, the robust expression of Igf1 and Igf2 in male
GCs [10], in particular spermatogonia, suggest that GCs
represent an important source of testicular IGFs which
may act in a paracrine manner to regulate different as-
pects of SC, LC or peritubular myoid cell, biology during
testis development and later in adult life. Thus, the possi-
bility remains that IGFs may play a role or even be re-
quired for the proliferation of gonocytes/spermatogonia.
In fact, data from an earlier study suggest that IGF1
and IGF2 have a selective paracrine or autocrine role in
the regulation of spermatogonial proliferation during
spermatogenesis [81].
IGFs mediate proliferation of fetal LCs and steroidogenic
function of adult LCs
In mammals, two distinct populations of LCs appear
during testis development: the fetal Leydig cells (FLCs)
and adult Leydig cells (ALCs) [82]. FLCs produce both
androgens and INSL3, which are responsible for the
masculinization of the urogenital system and testicular
descent (for a review see [83]). These cells regress there-
after, and are replaced by the ALC population, which ap-
pears during puberty. Currently, two major hypotheses
prevail in terms of FLC and ALC development and dif-
ferentiation. The first is that FLCs and ALCs originate
from the same progenitor population but some of these
progenitors remain dormant up until prepubertal devel-
opment when they develop into ALCs [84,85]. The sec-
ond hypothesis maintains that FLCs and ALCs originate
from distinct cell lineages with different origins and
function [86-88].
Several factors have been implicated in triggering the
differentiation of progenitor cells into FLCs, such as
Desert Hedgehog (DHH) [55-57,89-92] and the platelet-
derived growth factor (PDGF) family [58]. Interestingly,
there are numerous reports indicating that IGF1 is also
implicated in LC development and function. For ex-
ample, testosterone production is reduced by more than
80% in Igf1-null mice, and this deficiency is associated
with a significant developmental delay in LCs and al-
tered LH-stimulated androgen secretion in vitro [6].
Further reductions in the expression of steroidogenic
markers in the testis such as StAR, Cyp11a1 and
Cyp17a1 are also observed [6,93,94]. Altered steroido-
genic function in LCs is also indicated by increased levels
of 5α-reductase, the presence of immature LCs in the
adult testis, and modified ratios of 3α-androstanediol
to testosterone [93]. Moreover, when GH-deficient Snelldwarf mice, which have low IGF1 levels, are treated with
IGF1, LH receptors and steroidogenic responsiveness is
augmented, indicating that IGF1 induces the maturation
of LC function [95]. Consistent with these findings, the
reduction in ALC number in mice mutant for Igf1 [6,96]
is a consequence of altered proliferation and differenti-
ation of progenitor LCs between postnatal days 14 and
35, although the developmentally earlier LC stem cell
lineage is not affected [93]. Furthermore, IGF1 has been
shown to stimulate the proliferation of progenitor LCs
[97]. Overall, these data indicate that the IGF system
plays an important role not only in mediating the prolif-
eration of precursor LCs and the establishment of a nor-
mal number of ALCs, but also in the steroidogenic
capacity of ALCs.
Conclusions, perspectives and unanswered questions
Recent studies have unequivocally demonstrated the es-
sential role of the insulin family of growth factors in sex
determination and reproductive function. Specifically,
insulin/IGF signaling is absolutely required for testis dif-
ferentiation, and embryos lacking both Insr and Igf1r fail
to develop testes [7,9]. The local production of IGFs ap-
pears to be the major intratesticular signal controlling
SC number, testis size, and sperm output in mammals,
although insulin/IGF signaling appears not to be re-
quired in GCs. In addition, IGF1 plays an essential role in
the proliferation of precursor LCs, the establishment of a
normal number of ALCs, and proper steroidogenesis.
Although significant progress has been made with re-
gard to the role of the insulin family of growth factors in
reproductive development and function, many critical
questions remain unresolved. The first question pertains
to the specific source(s) of intratesticular IGFs. Multiple
cell types in the body are capable of synthesizing IGFs
and multiple cell types in the testis have been impli-
cated, although conclusive data on which are responsible
for local IGF production and secretion are still lacking.
The next obvious unanswered question is the precise
identity of the IGFs that are produced and secreted in
the testis. In general, IGF1 is normally associated with
adult functions while IGF2 is known to act during em-
bryonic development. It is not yet clear whether this
general pattern holds true for testis development and
function. The third area of investigation that needs fur-
ther exploration is determining the relative contributions
of endocrine, paracrine and autocrine effects of the IGFs
in the testis. A fourth area for further study is the pre-
cise mechanisms by which IGF signaling in the testis
regulates testicular development and function. For ex-
ample, the actions of the insulin/IGF family of growth
factors are mediated primarily through INSR and IGF1R
and activate two major signaling pathways, the MAPK
and PI3K pathway. FSHR activation also stimulates these
Griffeth et al. Basic and Clinical Andrology 2014, 24:12 Page 8 of 10
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be coordinated in SCs. Although INSR and IGF1R are
required for FSH-mediated SC proliferation [10], the
mechanism controlling these concerted actions in imma-
ture SCs is not completely understood. Lastly, the pre-
cise in vivo role of IGFs in LC differentiation and
steroidogenesis remains to be unraveled. Data from the
most recent studies have employed constitutive Igf1-
deficient mice, making it extremely difficult to pinpoint
local testis-specific mechanisms in such a noisy back-
ground. Again, the endocrine, paracrine and autocrine
actions of IGFs represent a recurring and important
theme in deciphering the roles of IGFs in testicular devel-
opment and function. Continued technological advances
in genomics, proteomics, and the availability of animal
models with cell-specific KOs of particular ligands or re-
ceptors will surely aid in the quest to understand the pre-
cise roles that the insulin family of growth factors plays
in reproductive development and function.
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